The role of EGFR‐TKIs as adjuvant therapy in EGFR mutation‐positive early‐stage NSCLC: A meta‐analysis

Abstract Background The role of adjuvant epidermal growth factor receptor tyrosine kinase inhibitors (EGFR‐TKIs) is not clear in early‐stage nonsmall‐cell lung cancer (NSCLC) patients. This meta‐analysis aims to compare the efficacy and safety of EGFR‐TKIs as adjuvant therapy with chemotherapy or pl...

Descripción completa

Detalles Bibliográficos

Autores principales:	Chutong Lin, Fengling Hu, Hongling Chu, Peng Ren, Shanwu Ma, Jingdi Wang, Jie Bai, Xuan Han, Shaohua Ma
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Wiley 2021-04-01
Colección:	Thoracic Cancer
Materias:	adjuvant treatment epidermal growth factor receptor tyrosine kinase inhibitors nonsmall‐cell lung cancer survival targeted therapy
Acceso en línea:	https://doi.org/10.1111/1759-7714.13874
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!